The strategy aims to enhance national health security, create jobs, promote innovation, and improve access to quality and affordable healthcare commodities while reducing the country’s reliance on imports.
The healthcare package forms part of a broader set of cooperation agreements covering education, green industry, vocational training, and support for small and medium-sized enterprises.
Japan will channel the support through the International Federation of Red Cross and Red Crescent Societies (IFRC), the World Food Programme (WFP), and the United Nations Children’s Fund (UNICEF).
Under the new structure, hospitals and clinics previously operating as NMC Oman will now operate under the Numa Health brand, while EMC will continue as a dedicated sub-brand focused on dermatology and aesthetic medicine.
Under the agreement, Tanmeyah will provide tailored financing solutions for healthcare providers, particularly small and medium-sized facilities that often face constraints in investing in digital infrastructure.
The acquisition ranks among AbbVie’s largest transactions in recent years and reflects the company’s strategy to expand its next-generation immunology medicines as competition intensifies across the sector.
Mumbai-based Innovcare Lifesciences operates across the Indian market and focuses on marketing, distributing, and selling pharmaceutical products, nutraceuticals, and cosmeceuticals.
Under the agreement, Biogen will integrate RayThera’s portfolio of anti-inflammatory and immune-modulating candidates into its broader research and development engine.
The funding comes at a critical time, with health officials warning that the outbreak caused by the rare Bundibugyo strain of Ebola could become one of the most severe in history.
The Respiratory Summit 2026, held in London, brought together representatives from the asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and chronic rhinosinusitis communities for the first time under a shared prevention agenda.